Euphorbia ebracteolata
Euphorbia ebracteolata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Euphorbia ebracteolata is a specialized plant species known for containing bioactive compounds within its roots, or radix. Research focused on its methanol extract has identified significant chemical constituents, including Jolkinolide A, ent-16alpha,17-dihydroxyatisan-3-one, and ent-Atisane-3beta,16alpha,17-triol. These unique chemical profiles contribute to the plant's notable cytotoxic activities when studied in laboratory settings. Investigations into these extracts have demonstrated potential efficacy against various challenging conditions such as cancer, edema, and ascites. Furthermore, the plant shows promise in addressing complex medical hurdles like multidrug resistance.
- Synonyms
- Galarhoeus Ebracteolatus · Euphorbia Ebracteolata F. Coreana · 6 more
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Root
Classification
Common Names
Euphorbia ebracteolata is a unique botanical species recognized by several distinct regional names. In certain contexts, it is referred to by its Japanese common names, マルミノウルシ and 月腺大戟. It is also known by the name 白狼毒, reflecting its specific cultural or linguistic associations. Additionally, the plant is identified in Korean as 붉은대극. These various designations highlight the diverse linguistic landscape surrounding this particular plant.
Sources: Catalogue of Life (COL)
Synonyms
Euphorbia ebracteolata is a botanical subject characterized by a complex web of taxonomic synonyms. This plant is closely linked to the name Galarhoeus ebracteolatus, which represents an alternative classification within its lineage. Furthermore, researchers have identified several distinct forms and varieties, including f. coreana, f. magna, and var. coreana. The species also encompasses the variety anhweiensis, adding further depth to its documented diversity. Understanding these overlapping designations is essential for accurate identification in botanical studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Euphorbia ebracteolata is a distinctive botanical specimen belonging to the vast kingdom Plantae. Within this expansive realm, it is specifically classified under the class Equisetopsida. The plant is a member of the order Malpighiales, showcasing its evolutionary connection to a diverse group of flowering plants. Furthermore, it falls under the family Euphorbiaceae, a group known for its unique physiological traits. Ultimately, this species is identified by its placement within the well-known genus Euphorbia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Euphorbia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Euphorbia ebracteolata is a specialized plant species found primarily throughout the temperate regions of Asia. Its natural distribution spans several key territories, including various parts of China such as the North-Central and Southeast provinces. Beyond mainland China, this species is also established within the Eastern Asian landscape. Specifically, it can be identified growing in the distinct environments of both Japan and Korea. This wide-ranging presence highlights the plant's ability to thrive across diverse East Asian ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Euphorbia ebracteolata is characterized by its distinct growth form as a herbaceous plant. This species functions as a self-supporting organism, maintaining its own structure within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Euphorbia ebracteolata has been identified as a source of bioactive diterpenoids, particularly within its root system. Researchers have isolated several unique compounds, including new diterpenoids such as yuexiandajisu D, E, and F. These chemical constituents were evaluated for their potential therapeutic properties through various cytotoxic assays. The studies specifically tested these compounds against ANA-1, B 16, and Jurkat tumor cell lines to determine their efficacy. Ultimately, the findings revealed significant cytotoxic activity in certain isolated diterpenoids, highlighting the plant's pharmacological importance.
Compounds
Euphorbia ebracteolata is a plant species that serves as a rich source of diverse chemical constituents. Research has successfully identified specific compounds within its roots, including 10-nonacosanol and 24-methylenecycloartanol. Furthermore, phytochemical investigations have isolated Compound 1, which is identified as a rare dinor-ent-isopimarane diterpenoid. The plant also contains notable diterpenoids such as Jolkinolide A and Jolkinolide B. These various compounds are of significant interest due to their potential biological activities and cytotoxic properties.
Conditions
Euphorbia ebracteolata demonstrates significant therapeutic potential through its ability to treat cancer and manage conditions such as ascites and edema. Research indicates that specific terpenoids derived from the plant possess multidrug resistance reversal activity, which helps overcome MDR in certain cell models. Additionally, the plant's chemical constituents have been studied for their capacity to treat anti-epilepsy symptoms as part of traditional Chinese medicine. These diverse biological activities are linked to various secondary metabolites, including newly identified euphebranones and ursane-type triterpenoids. Ultimately, the plant serves as a complex source of compounds capable of addressing MDR and various oncological and neurological ailments.
Preparations
Euphorbia ebracteolata is prepared as a methanol extract to facilitate the isolation of chemical constituents like 10-nonacosanol and stigmasterol. This plant is also prepared as radix for the phytochemical investigation of higher diterpenoids. Furthermore, Euphorbia ebracteolata is prepared as roots to study various cytotoxic compounds. These different preparation methods, including the use of the radix and roots, allow researchers to identify diverse bioactive molecules. Consequently, whether processed as a methanol extract or via its roots and radix, the plant serves as a vital source for medicinal compound discovery.
Parts used
Euphorbia ebracteolata serves as a significant subject in pharmacological research, particularly regarding the chemical potential of its roots. Scientific investigations into the traditional Chinese drug Langdu have focused on extracting effective anti-epilepsy components from this specific plant part. Through methanol extraction and spectroscopic analysis, researchers have successfully isolated several key compounds, including 10-nonacosanol and 24-methylenecycloartanol, directly from the roots. Furthermore, the root has proven to be a rich source of cytotoxic diterpenoids, such as yuexiandajisu D, E, and F. These findings highlight the importance of the root in identifying new bioactive molecules with potential applications in treating tumor cells.